Bioxytran Inc (BIXT)

[righton21]

You make a good point about the number of pills. Patients don't like taking a lot of pills or large ones so the dose optimization study is important for general use and adoption. Health care providers shy away from prescribing medications where patients complain about the size of the pills or how many or how often one needs to take them. Once a day and a small, easy to swallow pill is ideal. But a company can control that property to a certain extent by making the pills more or less potent and larger or smaller by adjusting the inert, carrier materials in the pill as the trial outcome dictates. The best we can hope for on this trial is that a small pill taken once a day for a short period of time is effective at eradicating the virus from the body. If that happens, BIXT is sitting on a gold mine!